Prognostic significance of serum translocator protein in patients with traumatic brain injury

Luo, LF; Weng, JF; Cen, M; Dong, XQ; Yu, WH; Du, Q; Yang, DB; Zheng, YK; Hu, W; Yu, L; Luo, SD

Weng, JF (reprint author), CHC Int Hosp, Dept Neurosurg, 599 Shiji Ave, Cixi 315315, Peoples R China.

CLINICA CHIMICA ACTA, 2019; 488 (): 25

Abstract

Background: Translocator protein (TP) is related to inflammation and is involved in brain injury. The objective of this study was to ascertain whether serum TP concentrations are associated with the severity and prognosis of traumatic brain injury (TBI). Methods: We quantified the serum concentrations of TP in 106 healthy controls and 106 patients with severe TBI. Recorded prognostic variables included acute lung injury, acute traumatic coagulopathy, progressive hemorrhagic injury, posttraumatic cerebral infarction, 6-month mortality and 6-month poor outcome (Glasgow Outcome Scale score of 1-3). Trauma severity was assessed by Glasgow coma scale (GCS) score. Extent of inflammatory response was indicated by serum interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-a) and C-reactive protein (CRP) concentrations. Results: Patients had significantly higher serum TP concentrations than controls. Among patients, serum TP concentrations strongly and independently correlated with GCS score and serum IL-6, TNF-a and CRP concentrations. Serum TP was identified as an independent predictor for the preceding prognostic variables, its prognostic predictive ability was similar to that of GCS score and it also significantly improved prognostic predictive ability of GCS score. Conclusion: Serum TP may be intimately linked with in inflammation, disease progression and poor prognosis in TBI patients.

Download PDF


Full Text Link